Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.26
Delayed Data
As of 3:59pm ET
 +0.02 / +0.28%
Today’s Change
6.90
Today|||52-Week Range
9.88
-15.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues63.1M60.8M60.5M61.7M
 
 
 
 
 
Cost of Goods Sold30.8M29.2M27.0M30.5M
 
 
 
 
 
Depreciation And Amortization5.4M6.0M6.2M5.7M
 
 
 
 
 
 
Operating ExpensesGross Income27.0M25.5M27.3M25.5M
 
 
 
 
 
General Expenses24.8M24.1M26.7M25.6M
 
 
 
 
 
Research And Development1.3M967.0K930.0K862.0K
 
 
 
 
 
Total Operating Expenses60.9M59.4M60.0M61.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.2M1.4M529.0K-115.0K
 
 
 
 
 
Extraordinary Charge0.000.00-3.5M0.00
 
 
Interest Expense On Debt1.4M1.5M5.5M1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income745.0K-73.0K-8.4M-1.5M
 
 
 
 
 
Income Taxes-332.0K-6.0K-2.2M-825.0K
 
 
 
 
 
Preferred Dividend-5.6M-5.6M-8.0M-2.6M
 
 
 
 
 
Net Income413.0K-67.0K-6.2M-654.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS77.4M78.1M78.5M78.7M
 
 
 
 
 
Shares To Calculate EPS Diluted77.4M78.1M78.5M78.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.07-$0.18-$0.04
 
 
 
 
 
EPS Diluted-$0.07-$0.07-$0.18-$0.04